http://www.lensociety.com/japan-eyedrops/
Ophthalmic Drug Market Analysis
As the saying goes: the eyes are the windows of the soul. See, people see the eyes and heart are equally important. Indeed, in the sense organs on the pharmaceutical market, ophthalmic drugs accounted for more than 70% market share.
Although the ophthalmic drug in a small proportion of drug desert, but it is a very high profit margins the past two years, a class of varieties, with the population growth and the acceleration of the process of aging society, ophthalmic drugs have become a star in the market .
From 2005, China’s ophthalmic market, the National Eye drug market has exceeded 1.5 billion, a number of ophthalmic drugs has become a high-profile species. Mainly in the ophthalmic anti-infective, anti-glaucoma, anti-cataract, pupil dilation and contraction as the leading class of drugs. With the development of modern society, particularly the universal application of computers, people fight fatigue, anti-demand for dry eye medications. Public manufacturers also taken a fancy to this opportunity, have joined the ranks of such products, we can easily find, at present, in many ophthalmic drugs, the anti-inflammatory, Run-head has become a key demand of eye drops.
Ophthalmic market characteristics
China is a high incidence of myopia of the country, from the crowd in the knowledge-based observation, and its incidence has more than 60%, on the other by the impact of modern office features, as well as the development of aging society, an annual incidence of dry eye 10% of the rate of increase, thus constituting a ophthalmic anti-inflammatory medication Run head a major consumer groups. At the same time, age-related cataract, glaucoma, there is gradual upward trend, and thus objectively a large amount of the ophthalmic drug market, along with health care, medical payments to open exponential growth in the level of ophthalmic drugs is ever increasing.
The incidence of eye disease is not high, but much people’s attention so that diagnosis and treatment rates have increased, and some age-related eye diseases pathological changes slowly, the length of a different course, and many eye diseases requires long-term medication after diagnosis, so the terminal market, the hospital occupies a major share of the retail pharmacies also account for a large proportion, so that the consumer market continued to grow.
Ophthalmic medicine naturally formed as an independent system of treatment also has a certain degree of particularity, in the formulation, the basic drug primarily constituted by the eye drops and eye ointments. At present, the hospital purchased all the medicines, ophthalmic drugs a total of 110 species, becoming the mainstay of ophthalmic products market.
Ophthalmic drugs in the 20th century, 70 years also as a subsidiary company of small products, since domestic and foreign markets, after a gradual convergence with the increasing competition and industrial structure refinement, ophthalmic drugs has developed a unique system, ophthalmic drug-producing plants have unique form a specialized industry groups.
Anti-infective class varieties, use large
Ophthalmic anti-infective drug with a variety of multi-class, a large amount of features, forming the main body of earning profits. At present, the sample hospital application of antibacterial / anti-inflammatory eyedrops for 34 classes. After years of development has changed the traditional chloramphenicol eye drops, erythromycin eye ointment a single structure, and gradually developed into the third-generation quinolone antibiotic eye drops and a variety of patterns of compound preparation, which has created Moisten, music don, Amway, and many other well-known brands.
Ophthalmic anti-infective drug in the class, the quinolones ofloxacin eye drops in a hospital in the amount of the largest species in the quinolone account for a share of more than 90%, from Ningbo Weihenstephan pharmaceutical products in 1993, to be allowed After listing, 2005, SFDA has approved 29 production, the output was more in Shenyang Xing Qi pharmaceutical, Hubei Dongsheng, Shanghai Pharmaceutical Co., Hsin Yi Jin Zhu, Jiangxi days Seacon and so on, the market’s major brands are available Luo Di, the letter was finalized, Amway, Connaught Green, and Santen Pharmaceutical Co., Ltd., Japan Tarivid.
Ofloxacin eye drops, “descendants” of levofloxacin eye drops, 2001, Santen Pharmaceutical Co., Ltd. of Japan listed species, their trade name “Iquix”. The goods in our country belongs to four new drugs, since 2002 the success of the domestic generic levofloxacin eye drops, at present, six enterprises have been awarded SFDA production approval, and the market. Levofloxacin eye drops medication in 2004 grew rapidly, with the previous year, an increase of 149%, main products including Zhongshan, Zhuhai branch of the federal “left Fukang”, Shandong Chia Tai Freda Pharmaceutical’s “Helen”, Jiangsu Yabang Epson Chinese medicine, “as states”, the Beijing Li Xiang Pharmaceutical’s “Longview”, Chongqing Pharmaceutical Corey’s “An Jing” and Hangzhou, Kuo Kuang Pharmaceutical levofloxacin eye drops. Currently, levofloxacin eye drops have been attributed to the “National Medical Insurance Drug List” in B. Levofloxacin eye drops due to excellent antimicrobial activity and strong penetration of the organization, has been a doctor, the patient’s endorsement.
The major class medicine sales trends
Glaucoma is a common disease in China, often referred to as the second-largest eye disease, eye diseases, accounting for 14.36%, accounting for blinding eye disease in the first four, the crowd in the incidence rate of about 0.12% to 1.64%. The prevalence of glaucoma increases with age, from 40-year-old began to increase in patients over 50 years of age the proportion of 68%, glaucoma is a great relationship and career as a eye disease. In recent years, Eye Hospital, a sample of anti-glaucoma and miosis showing a growing trend in medicine in 2004, the amount of these drugs increased 22% drug to treat glaucoma, there are 10 kinds of commonly used drugs, anti-glaucoma drugs are mainly β-adrenergic receptor blocking hysteresis agent carteolol, timolol maleate, latanoprost, clonidine hydrochloride, pilocarpine eye drops and so on.
A sample application from the National Eye Hospital, drug statistics statistics we can see, sales ranks No. 2 of the varieties antibiotic compound preparation of tobramycin / dexamethasone eye drops, first half of 2005 accounted for 6.37% of the share of the market, in which love Erkang company’s “tobradex” eye drops accounted for 99% of the goods, but in many competing brands, its market share has declined, domestic drug Shandong Qilu Pharmaceutical’s “Code of Shu,” only accounts for a % of the market.
Today’s market, more popular brands, such as the Chia Tai Freda is the sodium hyaluronate / chloramphenicol compound preparation “Moisten”, since 1995, after the listing of access to production approval to establish a new selling point of the product, not only in anti-inflammatory to promote cell migration, repair, corneal epidermal therapeutic areas opened up the situation, and in dry eye, lubrication, nutrition, the cornea has also been recognized by consumers, it was quickly opened the ophthalmology market, 2004 sales as high as 155 million, ophthalmic drugs accounted for 55% of the market, making it the largest circulation in domestic eyedrops, sales amount of the highest lucrative compound preparation of chloramphenicol eye drops.
Common varieties of chloramphenicol eye drops in the eye and its compound samples in the hospital anti-infective drugs account for about 7% of the share of ophthalmic anti-infective market in the country by about 12% to 15% of the share of output of the larger enterprises are Zhengda Furui up, Wuhan 5 King, Guangzhou Tianxin, Guangzhou East Kang, Shandong Lukang, Shenyang Xing Qi and so on, dozens of chloramphenicol eye drops in domestic manufacturers, the drug market parity, 1 yuan of chloramphenicol eye drops Liquid mainly occupy the third terminal, from the sales accounted for 80%, but only 20 percent of its sales, with the drug raises the level of market share will continue to shrink.
About the Author
I am a professional editor from
China Product
, and my work is to promote a free online trade platform.
http://www.himfr.com/ contain a great deal of information about
timer pill box
,
pill organizer
welcome to visit!
Pharmacy products in Japan – Eye drops
|
|
Innoxa French Blue Eye Drops Gouttes Bleues 10ml $11.99 Innoxa has been around since 1920. It has helped models, celebrities and anyone who wants clear vibrant colorful and sparkling eyes…. |
|
|
Can-c Eye-drops $39.90 Can-C Carnosine Eye Drops contains two 5ml vials of lubricant eye drops with n-acetylcarnosine. This product is NOT recommended for children, so always keep out of the reach of children. For external use only. Use with Can-C Plus …. |
|
|
Rohto V. Cooling Redness Reliever/Lubricant Eye Drops, .4 fl oz (13 ml) (Pack of 4) $19.04 Temporarily relieves burning and irritation due to dryness of the eye. Relieves redness of the eye due to minor eye irritations. Temporarily relieves burning and irritation due to dryness of the eye…. |
|
|
The Cataract Cure: The Russian eye-drop breakthrough: The story of N-acetylcarnosine $7.27 Author Marios Kyriazis brings a wealth of medical expertise to one of the most important breakthroughs in recent times to help combat a disease called senile cataract, which affects one in five people over the age of fifty-five. In the past, the only treatment available for this chronic condition was painful and potentially dangerous surgery to remove the cataract. Other treatments are now ava… |
